TrialSite News Releases Groundbreaking Documentary About Peru’s Use of Ivermectin for COVID-19

TrialSite News Production

TrialSite News Releases Groundbreaking Documentary Series “From The Front Lines” Spotlighting the Stories of Doctors, Clinicians, and Patients From Around the World Combating COVID-19, with the First Installation Focused on Peru’s Use of Ivermectin as an economical and widely available Therapeutic In this Fight For Life or Death

August 14, 2020

TrialSite News, the leading clinical-research-trial digital media platform, dedicated to independent and unbiased coverage and analysis of pharmaceutical trial developments from around the world, announces a groundbreaking new documentary series “From The Front Lines” chronicling the stories of doctors, clinicians and patients fighting the Covid-19 pandemic.  TrialSite News is proud to announce the release of the first installation focusing on the use of Ivermectin  to combat the Covid-19 pandemic in Peru.  What are the factors behind Ivermectin, a common anti-parasite drug approved by the U.S. Food and Drug Administration (FDA), becoming a standard treatment for SARS-CoV-2, the virus behind COVID-19 in Peru? To view the documentary go here

As the pandemic spread fromWuhan, China to the rest of the world, by March 20...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee